SCHEMBL10704473

SCHEMBL10704473

Cc1[nH]c(=O)c(C(N)=O)cc1-c1ccncc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNC P24863 3/20 0.67
CDK8 P49336 3/20 0.67
PDE3B Q13370 3/20 0.64
PDE3A Q14432 3/20 0.64
AURKB Q96GD4 1/20 0.64
INCENP Q9NQS7 1/20 0.64
CDC7 O00311 9/20 0.58
PDE4A P27815 2/20 0.56
PDE4B Q07343 2/20 0.56
PDE4C Q08493 2/20 0.56
PDE4D Q08499 2/20 0.56
KDM4E B2RXH2 1/20 0.56
PDE5A O76074 1/20 0.56
LMNA P02545 1/20 0.56
HPGD P15428 1/20 0.56
TSHR P16473 1/20 0.56
PTGS1 P23219 1/20 0.56
CYP2C19 P33261 1/20 0.56
BLM P54132 1/20 0.56
BTK Q06187 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11234900 0.87 PDE3B (0.61) CCNCCDK8PDE3BPDE3AAURKB
SCHEMBL11315754 0.85 PDE3B (0.62) CCNCCDK8PDE3BPDE3AAURKB
SCHEMBL11230846 0.85 PDE3B (0.59) CCNCCDK8PDE3BPDE3AAURKB
SCHEMBL11078693 0.85 MKNK1 (0.56) CCNCCDK8PDE3BPDE3AAURKB
SCHEMBL11084198 0.85 CCNC (0.53) CCNCCDK8PDE3BPDE3AAURKB
SCHEMBL10965436 0.84 CDC7 (0.51) CCNCCDK8PDE3BPDE3AAURKB
SCHEMBL11002239 0.84 PDE3B (0.49) CCNCCDK8PDE3BPDE3AAURKB
SCHEMBL9670148 0.83 CDC7 (0.54) CCNCCDK8PDE3BPDE3AAURKB
SCHEMBL11232569 0.83 CYP46A1 (0.58) CCNCCDK8PDE3BPDE3AAURKB
SCHEMBL10966927 0.83 CDK5 (0.64) CCNCCDK8CDC7CDK5CDK5R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4313951-A 3-Substituted-6-(lower-alkyl)-5-(pyridinyl)-2(1H)-pyridinones, their cardiotonic use and intermediates therefor STERLING DRUG INC. (US) 1982-02-02 US claimed
CN-116098861-A Milrinone injection and preparation method thereof 河南省肿瘤医院 2023-05-12 CN disclosed
CN-104173343-A Milrinone compound and pharmaceutical composition containing milrinone compound LANGTIAN PHARMACEUTICAL HUBEI CO LTD 2014-12-03 CN disclosed
EP-0127756-B1 PROCESS FOR THE PREPARATION OF 5-PYRIDYL-PYRIDINE-2(1H)-ONES FABRICA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS ABELLO, S.A. (ES) 1988-10-26 EP disclosed
US-4563528-A Process for preparing 5 pyridyl pyridine-2 (1H)-ones FABRICA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS ABELLO, S.A. (ES) 1986-01-07 US disclosed
EP-0127756-A1 Process for the preparation of 5-pyridyl-pyridine-2(1H)-ones FABRICA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS ABELLO, S.A. (ES) 1984-12-12 EP disclosed
US-4469871-A Process for preparing 2-(lower-alkoxy)-1-(pyridinyl) ethenyl lower-alkyl ketones STERLING DRUG INC. (US) 1984-09-04 US disclosed
EP-0095152-A1 A process for preparing nicotinonitriles and intermediates used therein STERLING DRUG INC. (US) 1983-11-30 EP disclosed
US-4417054-A 2-(Lower-alkoxy)-1-(pyridinyl)ethenyl lower-alkyl ketones STERLING DRUG INC. (US) 1983-11-22 US disclosed
US-4365065-A 1-(Pyridinyl)-2-(dimethylamino)ethenyl lower-alkyl ketones STERLING DRUG INC. (US) 1982-12-21 US disclosed
US-4313951-A 3-Substituted-6-(lower-alkyl)-5-(pyridinyl)-2(1H)-pyridinones, their cardiotonic use and intermediates therefor STERLING DRUG INC. (US) 1982-02-02 US disclosed